« Back to the previous page

Also available in:

Cancer Drug Development company in Eastern Europe for sale

Cancer Drug Development company in Europe for sale

  • Size: medium - size
  • Location of this manufacturer: Western Europe
  • Sales: <2 million EUR
  • #CFIE PHS026

Overview of this cancer drug development company

The owner of a contract research organization located in Western Europe decided to sell the business. The business is operated by experts who have affluent knowledge in developing new pharmaceutical products for the treatment and prevention of tumorous and metabolic diseases. The business primarily focuses on research and drug development related to deuterium depletion. Deuterium depletion also known as light water, is water with lower concentration of deuterium than naturally.

Profile (strategy) of this cancer drug development company

This company for sale is a drug development and cancer research company with sales around 2 million euro, situated in Western Europe.

The company has a well-defined concept to develop new drugs based on deuterium depletion and effective drugs for different indications.

It is not a new company on the market. The company was established in 19 and gained 25 years of experience in the research of deuterium depletion.

Deuterium depletion also known as light water, is water which has a lower concentration of deuterium than naturally. 

Currently employs 12 workers and has an exclusive partnership in given territory.

On top of that, it can also offer strong IP position and good reputation - has been selling products in more than 40 countries worldwide.

The research made by the company resulted in developing new products which are now available on the market.

Some of the products are: deuterium-depleted drinking waters for human consumption and anticancer medicinal product for veterinary use.

Targets for deuterium depletion: cancer, diabetes, high blood pressure, disease of lipid metabolism, prevention. 

The company is looking for:

Distributors for marketing and selling their products worldwide

Investors to launch Phase 2 clinical trials for different tumor types

License partners

Buy this cancer
drug development company

Contact us to get details about this company for sale

Activities and products of this cancer drug development company

 The company is developing new drugs based on deuterium depletion and effective drugs for different indications.

Has been selling products in more than 40 countries worldwide.

Developing and registering pharmaceutical and consumers products primarily for the treatment and prevention of tumorous and metabolic diseases.

Opening up new ways of application of the method in further ranges of indication.

Researching and inventing new ways how deuterium depletion can be used in treatment of cancer, diabetes, blood pressure, lipid metabolism and prevention.


 Highlights of the cancer drug development company 

  • It is a special contract research organization run by skilled experts. 
  • These highly skilled workers have rich experiences in developing new pharmaceutical products for the treatment and prevention of tumorous and metabolic diseases. 
  • Has been selling products in more than 40 countries worldwide.
  • Some of the products are: deuterium-depleted drinking waters for human consumption and anticancer medicinal product for veterinary use.
  • The company is actively looking for: distributors, investors to launch Phase 2 clinical trials for different tumor types, licensed partners

 Information about this cancer drug development company

 Feel free to contact us for more information regarding this clinical trial supplier for sale. If this cancer drug development company based in Western Europe for sale does not fit your requirements, feel free to ask for other cancer drug development company. For buyers of For buyers of pharma-related companies please visit the section pharma companies wanted.


Note: CFIE only works with formal companies. We do get a lot of requests and it is difficult to follow up on all inquiries from visitors to our website. For each company, we assess the likelihood of a future transaction. We only get back to you if we see a realistic opportunity to do a future acquisition or business sale. In order to increase your chances of receiving a reply as an individual, please explain as much as possible about your personal background, strategy and fit with the target. There is also a possibility that your details will be kept on file and we will get back to you once there is an opportunity to do a transaction. CFIE can’t guarantee you will receive an answer to your request.